Bio-Reference Labs (BRLI) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq set for sharp drop as Amazon, Intel amplify AI spending worries
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts BRLI Hot Sheet
Price: $4.70 --0%
Financial Fact:
NET INCOME PER COMMON SHARE - BASIC: (in dollars per share): 0.38
Today's EPS Names:
BNCC, ZVOI, SYRS, More
Financial Fact:
NET INCOME PER COMMON SHARE - BASIC: (in dollars per share): 0.38
Today's EPS Names:
BNCC, ZVOI, SYRS, More
Join SI Premium – FREE
Bio-Reference Labs (NASDAQ: BRLI) reported Q3 EPS of $0.55, $0.02 better than the analyst estimate of $0.53. Revenue for the quarter came in at $222.05 thousand versus the consensus estimate of $210.44 thousand.
For earnings history and earnings-related data on Bio-Reference Labs (BRLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Why Beijing could block the SpaceX-Tesla merger
- Piper Sandler Companies (PIPR) Misses Q3 EPS by 6c, Misses on Revenue
- Viatris launches $36.50-per-share tender offer for Pacira BioSciences
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
